HRP20010398B1 - Eletriptan hydrobromide monohydrate - Google Patents

Eletriptan hydrobromide monohydrate

Info

Publication number
HRP20010398B1
HRP20010398B1 HRP20010398A HRP20010398B1 HR P20010398 B1 HRP20010398 B1 HR P20010398B1 HR P20010398 A HRP20010398 A HR P20010398A HR P20010398 B1 HRP20010398 B1 HR P20010398B1
Authority
HR
Croatia
Prior art keywords
eletriptan hydrobromide
hydrobromide monohydrate
monohydrate
eletriptan
hydrobromide
Prior art date
Application number
Other languages
English (en)
Inventor
Christopher Ian Dallman
Ronald James Ogilvie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HRP20010398A2 publication Critical patent/HRP20010398A2/hr
Publication of HRP20010398B1 publication Critical patent/HRP20010398B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Electroluminescent Light Sources (AREA)
  • Lasers (AREA)
  • Indole Compounds (AREA)
HR20010398 1998-11-27 2001-05-24 Eletriptan hydrobromide monohydrate HRP20010398B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9825988.0A GB9825988D0 (en) 1998-11-27 1998-11-27 Indole derivatives
PCT/IB1999/001754 WO2000032589A1 (en) 1998-11-27 1999-11-01 Eletriptan hydrobromide monohydrate

Publications (2)

Publication Number Publication Date
HRP20010398A2 HRP20010398A2 (en) 2002-06-30
HRP20010398B1 true HRP20010398B1 (en) 2004-12-31

Family

ID=10843140

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010398 HRP20010398B1 (en) 1998-11-27 2001-05-24 Eletriptan hydrobromide monohydrate

Country Status (53)

Country Link
US (2) US20020013358A1 (zh)
EP (1) EP1135381B1 (zh)
JP (1) JP3777094B2 (zh)
KR (1) KR100413739B1 (zh)
CN (1) CN1131860C (zh)
AP (1) AP2001002149A0 (zh)
AR (1) AR024232A1 (zh)
AT (1) ATE273300T1 (zh)
AU (1) AU754731B2 (zh)
BG (1) BG64706B1 (zh)
BR (1) BR9915692A (zh)
CA (1) CA2352392C (zh)
CO (1) CO5150178A1 (zh)
CR (1) CR6325A (zh)
CU (1) CU23269A3 (zh)
CZ (1) CZ295472B6 (zh)
DE (1) DE69919388T2 (zh)
DK (1) DK1135381T3 (zh)
DZ (1) DZ2948A1 (zh)
EA (1) EA003551B1 (zh)
EE (1) EE04914B1 (zh)
ES (1) ES2224701T3 (zh)
GB (1) GB9825988D0 (zh)
GC (1) GC0000113A (zh)
GE (1) GEP20043183B (zh)
GT (1) GT199900202A (zh)
HK (1) HK1042898B (zh)
HN (1) HN1999000196A (zh)
HR (1) HRP20010398B1 (zh)
HU (1) HUP0105308A3 (zh)
ID (1) ID28802A (zh)
IL (1) IL141663A (zh)
IS (1) IS2238B (zh)
MA (1) MA26708A1 (zh)
MY (1) MY124078A (zh)
NO (1) NO320798B1 (zh)
NZ (1) NZ510055A (zh)
OA (1) OA11671A (zh)
PA (1) PA8485701A1 (zh)
PE (1) PE20001299A1 (zh)
PL (1) PL194503B1 (zh)
PT (1) PT1135381E (zh)
RS (1) RS50002B (zh)
SI (1) SI1135381T1 (zh)
SK (1) SK285774B6 (zh)
SV (1) SV1999000204A (zh)
TN (1) TNSN99221A1 (zh)
TR (1) TR200101493T2 (zh)
TW (1) TWI246512B (zh)
UA (1) UA68402C2 (zh)
UY (2) UY25823A1 (zh)
WO (1) WO2000032589A1 (zh)
ZA (1) ZA200102681B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
WO2004089365A1 (en) 2003-04-11 2004-10-21 Pfizer Limited Pharmaceutical combination comprising eletriptan and sodium bicarbonate
US6927296B2 (en) 2003-07-23 2005-08-09 Pfizer Inc. Process
GB0317229D0 (en) * 2003-07-23 2003-08-27 Pfizer Ltd Improved process
EP2093225A1 (en) 2007-05-01 2009-08-26 Plus Chemicals B.V. Process for preparing crystalline eletriptan hydrobromide form ß
WO2008150500A1 (en) * 2007-05-29 2008-12-11 Plus Chemicals, S.A. A process for preparing 5-bromo-3-[(r)-1-methyl-pyrrolidin-2-ylmethyl]-1h-indole
WO2009077858A2 (en) * 2007-12-17 2009-06-25 Actavis Group Ptc Ehf Novel hemioxalate salt of eletriptan
US20120027816A1 (en) * 2009-02-25 2012-02-02 Actavis Group Ptc Ehf Highly pure eletriptan or a pharmaceutically acceptable salt thereof substantially free of eletriptan n-oxide impurity
WO2010116386A2 (en) * 2009-04-08 2010-10-14 Biophore India Pharmaceuticals Pvt. Ltd. Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
US8754239B2 (en) 2010-01-19 2014-06-17 Sms Pharmaceuticals Limited Process for preparing eletriptan hydrobromide having α-form
WO2014063752A1 (en) 2012-10-26 2014-05-01 Synthon Bv Process for making crystalline form alpha of eletriptan hydrobromide
CN103893112A (zh) * 2012-12-31 2014-07-02 重庆圣华曦药业股份有限公司 氢溴酸依来曲普坦注射液
CN107954947A (zh) * 2016-10-14 2018-04-24 北京莱瑞森医药科技有限公司 沃替西汀氢溴酸盐晶型c及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952741A (en) 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
FR2624732B1 (fr) 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
US5474784A (en) 1990-03-02 1995-12-12 British Technology Group Limited Dispensing device
RO111767B1 (ro) 1990-10-15 1997-01-30 Pfizer Derivati de indol, procedee si intermediari pentru prepararea acestora, compozitii farmaceutice si metoda pentru tratarea unor afectiuni
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5464633A (en) 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9510223D0 (en) 1995-05-20 1995-07-19 Pfizer Ltd Therapeutic agent
TW448172B (en) * 1996-03-08 2001-08-01 Pharmacia & Upjohn Co Llc Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation
US5998462A (en) * 1996-12-16 1999-12-07 Allelix Biopharmaceuticals Inc. 5-alkyl indole compounds
GB9704498D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Chemical compound
US6166025A (en) 1997-07-03 2000-12-26 Pfizer Inc. Pharmaceutical compositions containing eletriptran hemisulphate and caffeine

Also Published As

Publication number Publication date
HUP0105308A3 (en) 2003-01-28
ATE273300T1 (de) 2004-08-15
BG64706B1 (bg) 2005-12-30
HK1042898A1 (en) 2002-08-30
HUP0105308A2 (hu) 2002-05-29
IS5868A (is) 2001-02-27
SK6992001A3 (en) 2002-01-07
SV1999000204A (es) 2000-10-16
CU23269A3 (es) 2008-04-09
ES2224701T3 (es) 2005-03-01
EA003551B1 (ru) 2003-06-26
UY25825A1 (es) 2000-08-21
PE20001299A1 (es) 2000-12-01
GC0000113A (en) 2005-06-29
IL141663A0 (en) 2002-03-10
EP1135381A1 (en) 2001-09-26
MY124078A (en) 2006-06-30
BR9915692A (pt) 2001-08-14
RS50002B (sr) 2008-09-29
CR6325A (zh) 2008-07-02
OA11671A (en) 2005-01-12
AR024232A1 (es) 2002-09-25
UA68402C2 (en) 2004-08-16
YU18801A (sh) 2003-07-07
UY25823A1 (es) 2001-08-27
WO2000032589A1 (en) 2000-06-08
PL194503B1 (pl) 2007-06-29
PL347928A1 (en) 2002-04-22
GEP20043183B (en) 2004-02-25
GT199900202A (es) 2001-05-19
CZ20011839A3 (cs) 2001-10-17
TWI246512B (en) 2006-01-01
EE200100285A (et) 2002-08-15
CA2352392A1 (en) 2000-06-08
EP1135381B1 (en) 2004-08-11
PA8485701A1 (es) 2000-09-29
TNSN99221A1 (fr) 2005-11-10
EA200100297A1 (ru) 2001-08-27
SK285774B6 (sk) 2007-08-02
JP3777094B2 (ja) 2006-05-24
GB9825988D0 (en) 1999-01-20
CZ295472B6 (cs) 2005-08-17
KR100413739B1 (ko) 2004-01-03
EE04914B1 (et) 2007-10-15
MA26708A1 (fr) 2004-12-20
JP2002531449A (ja) 2002-09-24
US20020013358A1 (en) 2002-01-31
NO320798B1 (no) 2006-01-30
BG105539A (en) 2001-12-29
CN1328554A (zh) 2001-12-26
CN1131860C (zh) 2003-12-24
ZA200102681B (en) 2002-07-02
TR200101493T2 (tr) 2002-02-21
HN1999000196A (es) 2005-11-26
AP2001002149A0 (en) 2001-06-30
CA2352392C (en) 2006-01-24
SI1135381T1 (en) 2004-10-31
PT1135381E (pt) 2004-10-29
DK1135381T3 (da) 2004-11-15
HK1042898B (zh) 2004-10-08
IS2238B (is) 2007-05-15
KR20010080594A (ko) 2001-08-22
DE69919388T2 (de) 2005-09-29
AU754731B2 (en) 2002-11-21
NZ510055A (en) 2004-11-26
DE69919388D1 (de) 2004-09-16
ID28802A (id) 2001-07-05
DZ2948A1 (fr) 2004-03-15
IL141663A (en) 2004-05-12
CO5150178A1 (es) 2002-04-29
NO20012584D0 (no) 2001-05-25
HRP20010398A2 (en) 2002-06-30
US20050131237A1 (en) 2005-06-16
NO20012584L (no) 2001-07-27
AU6225399A (en) 2000-06-19
US7238723B2 (en) 2007-07-03

Similar Documents

Publication Publication Date Title
GB9823101D0 (en) Pharmaceutically active compounds
IL137346A0 (en) Pharmaceutically active morpholinol
IL140578A0 (en) Dolastatin 15 derivatives
GB9823102D0 (en) Pharmaceutically active compounds
IL141663A0 (en) Eletriptan hydrobromide monohydrate
GB9823690D0 (en) Facilitating ablutions
GB9823063D0 (en) Direction finding unit
GB2337526B (en) Easy rockeries
PL330386A1 (en) Bathtub
GB9823174D0 (en) Alcon
EP1095026A4 (en) PHARMACEUTICAL AGENTS
AU138672S (en) Bowl
GB9810069D0 (en) Storage area
TW369881U (en) Pillow set
AU137045S (en) Pillow
AU136694S (en) Pillow
IL158978A0 (en) Pharmaceutically active morpholinol
GB9801230D0 (en) Pharmaceutically active morpholinol
PL327876A1 (en) Yieldable machining head
GB9822556D0 (en) Head rest
PL109039U1 (en) Bathtub
IL126353A0 (en) Soft barrier
GB9808160D0 (en) Urinal
PL108513U1 (en) Combination grill-heater
PL327557A1 (en) Micro-agitator for emulssions

Legal Events

Date Code Title Description
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
A1OB Publication of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20071018

Year of fee payment: 9

PBON Lapse due to non-payment of renewal fee

Effective date: 20081102